Skip to content

Efficacy of electroacupuncture in the treatment of classical trigeminal neuralgia with anxiety/depression and changes in brain regions observed based on fMRI

Efficacy of electroacupuncture in the treatment of classical trigeminal neuralgia with anxiety/depression and changes in brain regions observed based on fMRI

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079048
Enrollment
Unknown
Registered
2023-12-25
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Classical trigeminal neuralgia with anxiety/depression

Interventions

EA group:Local acupoints along the lesion branch of trigeminal nerve trunk were pricked withf0.18×25mm millimetre needles at a depth of about 5-10mm, and distal acupoints included bilateral Hegu, Waig
Sham EA group:Nonacupoints that were located 1 cm lateral to the same acupoints were selected. Electrodes were connected to nonacupoints near ST7/GB1 or ST7/SI18 or ST7/ST6 and LI4/SJ5. Notably, for s

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Fulfilment of the diagnostic criteria for CTN as described above (subjects meeting the first 4 diagnostic criteria were eligible for inclusion in the study); (2) Episodes involving the trigeminal branches; (3) Baseline VAS score =4, more than 3 seizures per day, and seizures at least 4 days per week; (4) 18 years = age = 80 years and gender; (5) BAI score =15 or BDI score =15; (6) Those who are conscious, have pain perception and discrimination ability, can complete normal communication and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Secondary trigeminal neuralgia due to intracranial tumours, multiple sclerosis, etc; (2) Head injury, epilepsy or other related neurological disorders; (3) Cognitive dysfunction, aphasia, or psychiatric disorders that make them unable to co-operate with treatment; (4) Pregnant or breastfeeding; (5) Not suitable to receive electroacupuncture therapy, such as those with pacemakers; (6) Patients who exclude pain-disordered psychiatric disorders; (7) Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
BAI/BDI;

Secondary

MeasureTime frame
fMRI;VAS score;BPI-Facial;

Countries

China

Contacts

Public ContactRongrong Li

The Third Affiliated Hospital of Zhejiang Chinese Medical University

425671918@qq.com+86 159 9011 4036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026